Abstract
Preclinical Efficacy and Phase I Clinical Testing of ATX-MS1467, an Antigen-Specific Immunotherapy for Multiple Sclerosis (P1.189)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1212/wnl.82.10_supplement.p1.189
Copy DOIJournal: Neurology | Publication Date: Apr 8, 2014 |
Preclinical Efficacy and Phase I Clinical Testing of ATX-MS1467, an Antigen-Specific Immunotherapy for Multiple Sclerosis (P1.189)
Join us for a 30 min session where you can share your feedback and ask us any queries you have